[HTML][HTML] Drug resistance in metastatic breast cancer: tumor targeted nanomedicine to the rescue

V Gote, AR Nookala, PK Bolla, D Pal - International journal of molecular …, 2021 - mdpi.com
Breast cancer, specifically metastatic breast, is a leading cause of morbidity and mortality in
women. This is mainly due to relapse and reoccurrence of tumor. The primary reason for …

Manipulating tumor hypoxia toward enhanced photodynamic therapy (PDT)

J Dang, H He, D Chen, L Yin - Biomaterials Science, 2017 - pubs.rsc.org
Photodynamic therapy (PDT) is considered a promising approach for the treatment of cancer
and is achieved via the photosensitizer (PS)-mediated incomplete reduction of oxygen upon …

Virological and immunological outcomes of coinfections

N Kumar, S Sharma, S Barua, BN Tripathi… - Clinical microbiology …, 2018 - Am Soc Microbiol
Coinfections involving viruses are being recognized to influence the disease pattern that
occurs relative to that with single infection. Classically, we usually think of a clinical …

The cubosome-based nanoplatforms in cancer therapy: Seeking new paradigms for cancer theranostics

BHJ Gowda, MG Ahmed, SA Alshehri, S Wahab… - Environmental …, 2023 - Elsevier
Lyotropic liquid crystals are self-assembled, non-lamellar, and mesophase nanostructured
materials that have garnered significant attention as drug carriers. Cubosomes, a subtype of …

Advances in receptor‐mediated, tumor‐targeted drug delivery

DE Large, JR Soucy, J Hebert… - Advanced …, 2019 - Wiley Online Library
Receptor‐mediated drug delivery presents an opportunity to enhance therapeutic efficiency
by accumulating drug within the tissue of interest and reducing undesired, off‐target effects …

Docetaxel: An update on its molecular mechanisms, therapeutic trajectory and nanotechnology in the treatment of breast, lung and prostate cancer

M Imran, S Saleem, A Chaudhuri, J Ali… - Journal of Drug Delivery …, 2020 - Elsevier
Amongst the various microtubule-targeting agents, Docetaxel (DTX) has gained immense
attention in cancer chemotherapy due to its good therapeutic index. DTX belongs to the …

Single-versus dual-targeted nanoparticles with folic acid and biotin for anticancer drug delivery

M Jurczyk, K Jelonek, M Musiał-Kulik, A Beberok… - Pharmaceutics, 2021 - mdpi.com
Cancer is one of the major causes of death worldwide and its treatment remains very
challenging. The effectiveness of cancer therapy significantly depends upon tumour-specific …

Theranostic combinatorial drug-loaded coated cubosomes for enhanced targeting and efficacy against cancer cells

L Zhang, J Li, D Tian, L Sun, X Wang, M Tian - Cell death & disease, 2020 - nature.com
Cubosomes, a product of nanobioengineering, are self-structured lipid nanoparticles that act
like drug-loaded theranostic probes. Here, we describe a simple method for the preparation …

pH Responsiveness of Hexosomes and Cubosomes for Combined Delivery of Brucea javanica Oil and Doxorubicin

Y Li, A Angelova, F Hu, VM Garamus, C Peng, N Li… - Langmuir, 2019 - ACS Publications
We report pH-responsive liquid crystalline lipid nanoparticles, which are dual-loaded by
Brucea javanica oil (BJO) and doxorubicin hydrochloride (DOX) and display a pH-induced …

Folate-conjugated nanovehicles: Strategies for cancer therapy

B Farran, RC Montenegro, P Kasa, E Pavitra… - Materials Science and …, 2020 - Elsevier
Cancer theranostics represents a strategy that aims at combining diagnosis with therapy
through the simultaneous imaging and targeted delivery of therapeutics to cancer cells …